Prevention and Early Detection of Congenital Heart Defects. Where do we stand.

Andreas Petropoulos

doi:10.28942/ejcs.v1i4.41

Vol. 1 No. 4 (2018)

Case & Short Reports

Prevention and Early Detection of Congenital Heart Defects. Where do we stand.

Published: April 8, 2021

DOI: https://doi.org/10.28942/ejcs.v1i4.41

Abstract

Introduction: Since the origin of Medicine in 4th BC. Century research has taught us that learning and practicing preventive medicine is properly the best method to prevent disease from happening in the first place. Preventive health care must be planned and executed ahead of time, even when illness/ disease, is absent, especially for those that are common and fаtal. Among neonates and infants, congenital heart disease (CHD) is responsible for the largest proportion of mortality caused by birth defects. Actual numbers of patients and mortality resulting from CHD reportedly is increasing. In the developed world the treatment of CHD has escalating costs for health care systems and private covered patients, while in low-income countries it is not always available. Prevention is urgently needed to tackle the increasing needs.

Aim: To present the current practice in preventing/early detecting CHD and justify why pulse oximetry is the best available, early detecting postnatal screening test we currently have.

Methods: The existing in use preventing/early detecting methods for avoiding or early diagnosing CHD are: 1. Eliminate the maternal risk factors by obtaining a good level of health and medical surveillance during pregnancy. 2. Avoiding teratogenic agents, 3. Detecting risk factors from Family History, 4. Delivering a balanced Nutrition during Pregnancy 5. Obtaining at least an experienced 4-chamber view and outflow tracts imaging during the 20-weeks anomaly scan. 6. Fetal Echocardiography when indicated 7. Postnatal evaluation by experienced Pediatricians. 8. Pulse Oximetry, screening test after 72 hours post-delivery in term babies. 9. Hyperoxia test when indicated.

Conclusion: Although CHD’s are the most common, high morbidity and mortality, congenital malformations, we still lack a single, easy to apply, non-invasive and low-cost screening test, for early detection. The current preventive methods must be combined to counterbalance the CHD prevalence. Meanwhile, they are costly and partially accessible. The most advantageous method for minimizing CHD deaths worldwide seems to be currently, pulse oximetry combined with clinical assessment.

Original publication: Petropoulos AC. Prevention and Early Detection of Congenital Heart Defects. Where do we Stand. J Cardiol 2018, 2(1): 000111.

References

1. Schiefsk M (2005) Hippocrates on Ancient Medicine. Brill Academic Publishers
2. Rudolf AM (2009) Congenital Diseases of the Heart-Clinical & Physiological Considerations 3rd (Edn.), Wiley- Blackwell.
3. Boyd PA, Devigan C, Garne E, Khoshnood B, Loane M, et al. (2005) Prenatal Screening Policies in Europe. EUROCAT Special Report, Ulster.
4. Knowles R, Griebsch I, Dezateux C, Brown J, Bull C, et al. (2005) Newborn screening for congenital heart defects: a systematic review and cost effectiveness analysis. Health Technol. Assess 9(44): 1-152.
5. (2013) Jekel's Epidemiology, Biostatistics, Preventive Medicine, and Public Health Publisher 4th (Edn.), Saunders.
6. Mitchell SC, Korones SB, Berendes HW (1971) Congenital heart disease in 56,109 births. Incidence and natural history. Circulation 43(3): 323-332.
7. Wren C (2012) The epidemiology of cardiovascular malformations. In: Moller JH, Hoffman JIE, Benson DW, van Hare GF, Wren C (Eds.), Pediatric Cardiovascular Medicine. Wiley-Blackwell, Oxford, England, pp: 268-275.
8. Hoffman JIE (2013) The global burden of congenital heart disease Cardiovasc. Cardiovasc J Afr 24(4): 141-145.
9. Petropoulos AC, Moschovi M, Xudiyeva A, Qarayev F, Isayev I (2017) Late Coarctation Presenters Suffer Chronic Hypertension Resisting to Medicine Treatment. Peertechz J Pediatr Ther 3(1): 001-008.
10. (2012) Ministry of Health of the People’s Republic of China. National birth defects control and prevention report.
11. List_of_sovereign_states_and_dependent_territories_b y_fertility_rate
12. Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, et al. (2012) Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation 126(9): 1143-1172.
13. Bernier PL, Stefanescu A, Samoukovic G, Tchervenkov CI (2010) The challenge of congenital heart disease worldwide: epidemiologic and demographic facts. Sem thorac cardiovasc surg. Pediatr Card Surg A 13: 26-34.
14. Brent RL (2004) Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics 113(4S): 957-968.
15. Petropoulos AC, Xudiyeva A, Ismaylova M (2016) Congenital Heart Disease and Maternal Diabetes Mellitus. International Journal of Diabetes & Clinical Diagnosis 3: 118.
16. Bader RS, Hornberger LK, Huhta JC (2008) The Perinatal cardiology 1st (Edn.), Handbook, Elsevier Inc, Mosby.
17. Midan MF, Alsheemy RI, Eid SM, Salam MEA (2016) Efficacy of fetal echocardiography in prenatal diagnosis of congenital heart diseases. Int J Reprod Contracept Obstet Gynecol 5(5): 1553-1557.
18. Kleiman CS, Hoddins JC, Jaffee CC, Lynch DC, Talner NS (1980) Echocardiography studies of the human fetus: prenatal diagnosis of congenital heart disease and cardiac dysrhythmias. Pediatrics 65(6): 1059-1067.
19. Simpson JM (2009) Impact of fetal echocardiography. Ann Pediatr Cardiol 2(1): 41-50.
20. Carvalho JS, Moscoso G, Tekay A, Campbell S, Thilaganathan B, et al. (2004) Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies, Heart 90(8): 921-926.
21. Maiz N, Nicolaides KH (2010) Ductus Venosus in the First Trimester: Contribution to Screening of Chromosomal, Cardiac Defects and Monochorionic Twin Complications, Fetal Diagn Ther 28(2): 65-71.
22. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, et al. (2003) First-Trimester Screening for Trisomy’s 21 and 18, N Engl. J Med 349(15): 1405-1413.
23. Rocha LA, Araujo Júnior E, Machado Nardozz LM, Moron AF (2013) Screening of fetal congenital heart disease: the challenge continues, Rev Bras Cir Cardiovasc 28(3): 5-7.
24. (2006) International Society of Ultrasound in Obstetrics & Gynecology. Cardiac screening
25. examination of the fetus: guidelines for performing the ‘basic’ and ‘extended basic’ cardiac scan. Ultrasound Obstet Gynecol 27(1): 107-113.
26. Quartermain MD, Pasquali SK, Hill KD, Goldberg DJ, Huhta JC, et al. (2015) Variation in Prenatal Diagnosis of Congenital Heart Disease in Infants, Pediatrics 136(2): e378-385.
27. (2016) Textbook of Neonatal Resuscitation Program (7th edition) Update; AAP.
28. Qu-ming Zhao, Xiao-jing Ma, Xiao-ling Ge, Fang Liu, Wei-li Yan, et al. (2014) Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China:a prospective study, The Lancet 384(9945): 747-754.
29. de Wahl Granelli A, Wennergren M, Sandberg K, Mellander M, Bejlum C, et al. (2009) Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ 338: a3037.

Prevention and Early Detection of Congenital Heart Defects. Where do we stand.

Abstract

References

Keywords

Most read articles by the same author(s)